Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
The unique mechanism of tirzepatide involves greater affinity for GIP receptors while maintaining significant activity at GLP-1 receptors. This dual action profile has shown promising results in metabolic research, particularly in studies of hyperglycemia reduction.
Our pharmaceutical grade tirzepatide is supplied as a white to off-white powder with 99% purity, suitable for research applications. The product is carefully packaged to ensure stability and proper handling.
For researchers looking to buy tirzepatide online, we offer flexible quantities and packaging options to meet various experimental requirements. The compound's molecular characteristics include a molecular weight of 813.92000 g/mol and precise pharmacological activity.
Important Note: This product is intended for research purposes only, not for human consumption. Proper laboratory handling procedures should always be followed when working with tirzepatide or any research compounds.